Fluorescence detection method for activity of alkaline phosphatase and application

The fluorescence detection method using 1-sodium naphthalenephosphate and ethylenediamine addresses pH sensitivity and interference issues, providing rapid and sensitive ALP detection in diverse environments.

CN119064333APending Publication Date: 2024-12-03QUFU NORMAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411468076.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-21
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing fluorescence detection methods for alkaline phosphatase (ALP) activity suffer from pH sensitivity issues, low sensitivity, high background interference, small Stokes shift, and long detection times, especially in soft acid environments like tumors, limiting their effectiveness.

Method used

A fluorescence detection method using 1-sodium naphthalenephosphate as a substrate, which generates naphthol upon reaction with alkaline phosphatase, and subsequent reaction with ethylenediamine, allowing for fluorescence detection under 355 nm excitation, providing high sensitivity, large Stokes shift, and reduced background interference, suitable for various pH conditions.

Benefits of technology

The method achieves rapid and sensitive ALP detection with strong fluorescence intensity, low light damage, and effective sample penetration, enabling accurate detection in both normal and tumor cells, serum, and organs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119064333A_ABST
    Figure CN119064333A_ABST
Patent Text Reader

Abstract

The embodiment of the invention relates to a fluorescence detection method and application of alkaline phosphatase activity, the fluorescence detection method comprises the following steps: mixing a substrate and a to-be-detected solution, reacting to generate naphthol, and obtaining a mixed solution A, mixing the mixed solution A with ethylenediamine, and reacting to obtain a mixed solution B; and carrying out fluorescence detection on the fluorescence generated by the mixed solution B under the excitation of 355 nm light wavelength by using a fluorescence spectrometer to obtain the concentration of alkaline phosphatase in the to-be-detected solution, so that the fluorescence detection method can reduce the influence of pH on fluorescence detection, can improve the detection sensitivity in a soft acid environment of tumors, has large Stokes shift, and can be used for detecting the alkaline phosphatase in the to-be-detected solution to obtain the alkaline phosphatase concentration of the to-be-detected solution. The detection time can be shortened, and the stability of fluorescence intensity is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of bioluminescence detection, and more specifically, to a fluorescence detection method and application of alkaline phosphatase activity. Background Art

[0002] Alkaline phosphatase (ALP) is an enzyme widely distributed in human liver, bones, intestines, kidneys and placenta, and excreted from the liver to the gallbladder. It is involved in many aspects of life activities, including metabolism, molecular transport, signal transduction and expression of genetic information. Downregulation of ALP is related to many diseases. ALP is mainly used for the diagnosis and differential diagnosis of bone and hepatobiliary system diseases. Therefore, it is extremely important to develop a sensitive and highly selective method for quantitative detection of ALP levels in serum. At present, there are many methods for monitoring ALP activity, such as fluorescence, electrochemical, colorimetric, surface enhanced Raman scattering, and chemiluminescence. Among them, electrochemical and surface enhanced Raman scattering are well established but the steps are complicated, and the traditional colorimetric method has low anti-interference ability and low sensitivity. In comparison, the fluorescence method usually has the characteristics of low background interference, high sensitivity, and strong anti-interference ability. Therefore, the main progress in ALP activity detection is focused on the design of fluorescence strategies. Since the analyte usually does not fluoresce, appropriate fluorescent substances must be introduced into the analysis system. These fluorescent substances play a core role in fluorescence analysis, such as organic dyes, nanomaterials, etc.

[0003] The organic dyes involved in ALP fluorescence determination are usually small molecules with diverse structures. The design method for detecting ALP activity probes is generally to phosphorylate the hydroxyl group of a small molecule fluorophore. The phosphorylated fluorophore has no fluorescence signal or has a weak fluorescence signal. When ALP is present, the phosphate group is removed and the fluorophore is restored. However, the existing fluorescent substrates are greatly affected by pH and cannot be sensitively detected in the soft acid environment of the tumor; the Stokes shift of the fluorescent substance is small, resulting in higher background interference; the fluorescence detection time is long, which is not conducive to improving the detection efficiency; the fluorescence intensity obtained by fluorescence detection is weak. Summary of the invention

[0004] The present application is provided to solve the above-mentioned defects existing in the prior art. A fluorescence detection method and application of alkaline phosphatase activity is needed, which can reduce the influence of pH on fluorescence detection, improve the sensitivity of detection in the soft acid environment of tumors, have a large Stokes shift, shorten the detection time, and improve the stability of fluorescence intensity.

[0005] In a first aspect of the present application, a fluorescence detection method for alkaline phosphatase activity is provided, the fluorescence detection method comprising: mixing a substrate with a test solution, the substrate comprising sodium 1-naphthylphosphate, reacting to generate naphthol, and obtaining a mixed solution A; mixing the mixed solution A with ethylenediamine, and obtaining a mixed solution B after reaction; and using a fluorescence spectrometer to perform fluorescence detection on the fluorescence generated by the mixed solution B under excitation of a light wavelength of 355 nm to obtain the concentration of alkaline phosphatase in the test solution.

[0006] The second aspect of the present application provides an application of the fluorescence detection method described in any embodiment of the present application in detecting alkaline phosphatase activity in cells, serum and / or organs.

[0007] The fluorescent detection method and application of alkaline phosphatase activity provided in each embodiment of the present application use 1-sodium naphthalenephosphate as a substrate, which is mixed with a test liquid, and the alkaline phosphatase in the test liquid reacts with 1-sodium naphthalenephosphate to generate naphthol. After the naphthol reacts with ethylenediamine, a high fluorescence intensity can be obtained under the excitation of 355nm light wavelength. The alkaline phosphatase concentration and fluorescence intensity conform to the linear law, which is convenient for fluorescence detection; the reaction time in the detection process is short, which can shorten the detection time. More importantly, using 1-sodium naphthalenephosphate as a substrate, the obtained fluorescent substrate can adapt to different pH conditions, so that it can be used to detect alkaline phosphatase activity in tumor cells, serum and organs, and can still produce a strong fluorescence intensity in a soft acid environment such as tumor cells; using 1-sodium naphthalenephosphate as a substrate, the detection result has a large Stokes shift, low background interference, small light damage to biological samples, strong sample penetration, and high detection sensitivity. BRIEF DESCRIPTION OF THE DRAWINGS

[0008] In the drawings, which are not necessarily drawn to scale, the same reference numerals may describe similar parts in different views. The same reference numerals with letter suffixes or different letter suffixes may represent different instances of similar parts. The accompanying drawings generally illustrate various embodiments by way of example and not limitation, and together with the specification and claims, are used to illustrate the embodiments applied for. When appropriate, the same reference numerals are used throughout the drawings to refer to the same or similar parts. Such embodiments are illustrative and are not intended to be exhaustive or exclusive embodiments of the present apparatus or method.

[0009] Figure 1 The fluorescence spectra at different pH values ​​according to Example 1 of the present application are shown; Figure 2 The fluorescence spectra at different pH values ​​according to Comparative Example 1 of the present application are shown; Figure 3 The fluorescence intensity diagram under different 1-naphthyl sodium phosphate concentrations according to Example 2 of the present application is shown; Figure 4The fluorescence intensity diagram at different ethylenediamine volume fractions according to Example 3 of the present application is shown; Figure 5 The fluorescence intensity diagrams of the mixed solution C according to Example 4 of the present application and the ALP solution at different reaction times are shown; Figure 6 The fluorescence intensity diagram of the mixed solution A and the ethylenediamine solution at different reaction times according to Example 5 of the present application is shown; Figure 7 A linear correlation diagram showing different ALP activities and fluorescence intensities within the range of 0-800 mU / mL according to Example 6 of the present application; Figure 8 A linear correlation diagram showing different ALP activities and fluorescence intensities within the range of 0-100 mU / mL according to Example 6 of the present application; Fig. 9 A linear correlation diagram between different ALP activities and fluorescence intensity within the range of 0-6 mU / mL according to Example 6 of the present application is shown; Fig.10 The cytotoxicity of 1-naphthyl sodium phosphate to Hepg2 cells according to Experimental Example 1 of the present application is shown; Fig.11 The cytotoxicity graph of 1-naphthyl sodium phosphate to LO2 according to Experimental Example 1 of the present application is shown; Fig.12 The cytotoxicity of ethylenediamine to Hepg2 cells according to Experimental Example 1 of the present application is shown; Fig.13 A diagram showing the cytotoxicity of ethylenediamine to LO2 according to Experimental Example 1 of the present application; Fig.14 Shows the fluorescence intensity graph of different cells according to Example 7 of the present application; Fig.15 ALP activity diagram of different cells according to Example 7 of the present application is shown; Fig.16 The test results of serum with different ALP activities according to Example 8 of the present application are shown; Fig.17 The fluorescence intensity diagram of each organ of the tumor mouse according to Example 9 of the present application is shown; Fig.18 ALP activity diagram of various organs of tumor mice according to Example 9 of the present application is shown; Fig.19 FIG. 9 shows the fluorescence intensity diagram of each organ of a normal mouse according to Example 9 of the present application; Fig. 20 A graph showing the ALP activity of various organs of normal mice according to Example 9 of the present application. DETAILED DESCRIPTION

[0010] In order to enable those skilled in the art to better understand the technical solution of the present application, the present application is described in detail below in conjunction with the accompanying drawings and specific implementation examples. The embodiments of the present application are further described in detail below in conjunction with the accompanying drawings and specific implementation examples, but are not intended to limit the present application.

[0011] The words "first", "second" and similar words used in this application do not indicate any order, quantity or importance, but are only used to distinguish. The words "include" or "comprise" and similar words mean that the elements before the word include the elements listed after the word, and do not exclude the possibility of including other elements.

[0012] According to an embodiment of the present application, a fluorescence detection method for alkaline phosphatase activity is provided, the fluorescence detection method comprising: mixing a substrate with a test liquid, the substrate comprising sodium 1-naphthylphosphate, reacting to generate naphthol, and obtaining a mixed solution A; mixing the mixed solution A with ethylenediamine, and obtaining a mixed solution B after reaction; and using a fluorescence spectrometer to perform fluorescence detection on the fluorescence generated by the mixed solution B under excitation of a light wavelength of 355 nm, to obtain the concentration of alkaline phosphatase in the test liquid.

[0013] Sodium 1-naphthylphosphate cannot react with ethylenediamine to produce fluorescence, while ALP can react with sodium 1-naphthylphosphate to remove the phosphate group of sodium 1-naphthylphosphate and obtain the product naphthol. The fluorescent substrate generated by the reaction of naphthol and ethylenediamine can produce blue fluorescence under the excitation of 355nm light. The fluorescence intensity is related to the activity of ALP. The fluorescent substrate has good adaptability to pH and can produce strong fluorescence after being excited under different pH environmental conditions. The maximum intensity of strong light under different pH is not much different. In this way, ALP can be detected in tumor cells, normal cells, serum, and mouse organs.

[0014] Sodium 1-naphthyl phosphate was selected as the main component of the substrate mainly because it is relatively stable, has a larger conjugate, and the generated product is more stable and has a stronger fluorescence intensity.

[0015] In some embodiments, the fluorescence generated by the mixed solution B under the excitation of 355nm light wavelength is detected by fluorescence spectrometer to obtain the activity of the alkaline phosphatase to be tested, including: using a fluorescence spectrometer to detect the fluorescence generated by the mixed solution B under the excitation of 355nm light wavelength to obtain a fluorescence spectrum; based on the fluorescence spectrum, the fluorescence intensity at 479nm is obtained; based on the linear relationship between the fluorescence intensity at 479nm and the alkaline phosphatase activity, the activity of alkaline phosphatase is obtained. In the range of 0-100 mU / mL, it is linearly correlated with the fluorescence intensity at 479nm, and then the ALP activity can be obtained. In the range of ALP activity greater than 100 mU / mL, the ALP activity and the fluorescence intensity present a related curve relationship.

[0016] Compared with the excitation wavelength of 355 nm, the wavelength difference of 479 nm is greater than 100 nm, indicating that the fluorescent substrate produced after the reaction of the present application has a large Stokes shift, low background interference, little light damage to biological samples, strong sample penetration, and high detection sensitivity.

[0017] In some embodiments, the substrate comprises a 1-naphthyl sodium phosphate solution, wherein the concentration of 1-naphthyl sodium phosphate in the 1-naphthyl sodium phosphate solution is 200-600 μmol / L, preferably 300-550 μmol / L. In some embodiments, the volume ratio of the 1-naphthyl sodium phosphate solution to the substrate is 1:2-6. The amount of 1-naphthyl sodium phosphate added to the 1-naphthyl sodium phosphate solution affects the fluorescence intensity.

[0018] In some embodiments, the volume ratio of the 1-naphthyl sodium phosphate solution to the test solution is 1-4:1.

[0019] In some embodiments, after the mixed solution A and the ethylenediamine solution are mixed and reacted, the volume ratio of the mixed solution A to the ethylenediamine solution is 5-40:1; and the volume fraction of the ethylenediamine solution is 40-60%. Preferably, the volume ratio of the mixed solution A to the ethylenediamine solution is 6-15:1; and the volume fraction of the ethylenediamine solution is 50%.

[0020] In some embodiments, the volume fraction of ethylenediamine in the mixed solution B is 1-15%; preferably, the volume fraction of ethylenediamine in the mixed solution B is 1-8%. The volume fraction of ethylenediamine in the mixed solution B affects the generated fluorescence intensity.

[0021] In some embodiments, the reaction time of mixing 1-naphthyl sodium phosphate with the test solution is 5-80 min; the reaction time of mixing solution A with ethylenediamine is 5-100 min. Preferably, the reaction time of mixing 1-naphthyl sodium phosphate with the test solution is 5-35 min. This short reaction time can save detection time and obtain a higher fluorescence intensity.

[0022] In some embodiments, the concentration of alkaline phosphatase in the test solution ranges from 0 to 800 mU / mL. Preferably, the concentration of alkaline phosphatase in the test solution ranges from 0 to 100 mU / mL.

[0023] In some embodiments, the substrate further comprises a mixed solution D, wherein the mixed solution D contains MgCl2 and Tris-HCl buffer. In some embodiments, the volume ratio of the mixed solution D to the substrate is 1:4-6. In some embodiments, the molar concentration of MgCl2 in the mixed solution D is 40-60 μmol / L. In some embodiments, the molar concentration of the Tris-HCl buffer in the mixed solution D is 40-60 mmol / L.

[0024] In some embodiments, the substrate further includes solvent water, and the volume ratio of the solvent water to the substrate is 1:1-3; preferably, the volume ratio of the solvent water to the substrate is 1:1.5-3.

[0025] In some embodiments, the temperature for the mixed reaction of the substrate and the test solution is 30-40° C.; the temperature for the mixed reaction of the mixed solution A and ethylenediamine is 30-40° C. The reaction temperature is appropriate and harsh reaction conditions are not required.

[0026] According to the embodiments of the present application, there is also provided an application of the fluorescence detection method described in any embodiment of the present application in detecting alkaline phosphatase activity in cells, serum and / or organs.

[0027] In some embodiments, the cells include tumor cells and / or normal cells. Both tumor cells and normal cells can be tested for ALP activity.

[0028] Example 1 (1) A mixed solution D of Tris-HCl buffer and MgCl2, a 1-naphthyl sodium phosphate solution (the solvent of the 1-naphthyl sodium phosphate solution is water) and solvent water are mixed to obtain a mixed solution C (substrate). The molar concentration of MgCl2 in the mixed solution D is 50 μM (μmol / L), the molar concentration of Tris-HCl buffer in the mixed solution D is 50 mM (mmol / L), the volume of the mixed solution D is 360 μL, and the pH of the mixed solution D is 6, 7, 8, 9 and 10. The volume of the 1-naphthyl sodium phosphate in the mixed solution C is 450 μL, the molar concentration of the 1-naphthyl sodium phosphate solution is 2.0 mM (mmol / L), and the volume of the solvent water is 810 μL.

[0029] (2) Mixed solution C was mixed with 180 μL of ALP solution (the ALP activity in the ALP solution was 0.9 U / mL, and the solvent of the ALP solution was water) and incubated in a constant temperature water bath at 37°C for 60 min to obtain mixed solution A.

[0030] (3) Mixed solution A was mixed with 200 μL of ethylenediamine solution (50% by volume, the solvent of the ethylenediamine solution was water) and placed at 37°C for 90 min to obtain mixed solution B. If the volume of mixed solution B was less than 2 mL, it was made up to 2 mL with deionized water.

[0031] (4) For each pH value, three samples were prepared in parallel and the fluorescence intensity at 479 nm in the fluorescence spectrum of mixed solution B obtained under the excitation of 355 nm light was measured.

[0032] Get as Figure 1 The results shown by Figure 1It can be seen that the pH of the substrate in which sodium 1-naphthylphosphate is located is different, and the fluorescence intensity at 479 nm is the highest. And under different pH conditions, the fluorescence intensity at 400-600 nm is not much different.

[0033] Comparative Example 1 The difference from Example 1 is that step (3) is not performed, and in step (4), the mixed solution A is excited by 355 nm light, and the fluorescence intensity of the excited fluorescence is detected.

[0034] Get as Figure 2 The results shown by Figure 2 It can be seen that under different pH conditions, the fluorescence intensity is small, and the maximum fluorescence intensity at 479 nm is less than 3000 (au).

[0035] By comparing Experimental Example 1 with Comparative Example 1, it can be seen that the fluorescence detection method using the combination of sodium 1-naphthylphosphate and ethylenediamine can obtain a stronger fluorescence intensity. In addition, pH has little effect on the fluorescence detection method of the present application, which is conducive to application under different pH conditions.

[0036] Example 2 (1) A mixed solution D of Tris-HCl buffer and MgCl2, a 1-naphthyl sodium phosphate solution (the solvent of the 1-naphthyl sodium phosphate solution is water) and solvent water are mixed to obtain a mixed solution C. The molar concentration of MgCl2 in the mixed solution D is 50 μM (μmol / L), the molar concentration of Tris-HCl buffer in the mixed solution D is 50 mM (mmol / L), the volume of the mixed solution D is 360 μL, and the pH of the Tris-HCl buffer is 6. The volume of the 1-naphthyl sodium phosphate solution in the mixed solution C is 300 μL, and the molar concentration of the 1-naphthyl sodium phosphate solution is 2.0 mM (mmol / L). The corresponding concentrations of the 1-naphthyl sodium phosphate in the mixed solution C are 300 μM (μmol / L), and the volume of the solvent water is 960 μL.

[0037] (2) Mixed solution C was mixed with 180 μL of ALP solution (the ALP activity in the ALP solution was 0.9 U / mL, and the solvent of the ALP solution was water) and incubated in a constant temperature water bath at 37°C for 60 min to obtain mixed solution A.

[0038] (3) Mixed solution A was mixed with 200 μL of ethylenediamine solution (50% by volume, the solvent of the ethylenediamine solution was water) and placed at 37°C for 90 min to obtain mixed solution B. If the volume of mixed solution B was less than 2 mL, it was made up to 2 mL with deionized water.

[0039] (4) For each pH value, three samples were prepared in parallel and the fluorescence intensity at 479 nm in the fluorescence spectrum of mixed solution B obtained under the excitation of 355 nm light was measured.

[0040] Different from the above steps, the added volumes of 1-naphthyl sodium phosphate solution in step (1) are 350 μL, 400 μL, 450 μL, 500 μL, and 550 μL, respectively, so that the concentrations of 1-naphthyl sodium phosphate solution are 350 μM (μmol / L), 400 μM (μmol / L), 450 μM (μmol / L), 500 μM (μmol / L), and 550 μM (μmol / L), respectively, and the corresponding fluorescence intensities are detected. The volume of 1-naphthyl sodium phosphate solution added in step (1) is 350 μL, and the corresponding volume of solvent water is 910 μL; the volume of 1-naphthyl sodium phosphate solution added in step (1) is 400 μL, and the corresponding volume of solvent water is 860 μL; the volume of 1-naphthyl sodium phosphate solution added in step (1) is 450 μL, and the corresponding volume of solvent water is 810 μL; the volume of 1-naphthyl sodium phosphate solution added in step (1) is 500 μL, and the corresponding volume of solvent water is 750 μL; the volume of 1-naphthyl sodium phosphate solution added in step (1) is 550 μL, and the corresponding volume of solvent water is 690 μL.

[0041] Get as Figure 3 The results shown by Figure 3 It can be seen that as the concentration of sodium 1-naphthylphosphate increases, the fluorescence intensity gradually increases and gradually decreases after 450 μM.

[0042] Example 3 (1) A mixed solution D of Tris-HCl buffer and MgCl2, a 1-naphthyl sodium phosphate solution (the solvent of the 1-naphthyl sodium phosphate solution is water) and solvent water are mixed to obtain a mixed solution C. The molar concentration of MgCl2 in the mixed solution D is 50 μM (μmol / L), the molar concentration of Tris-HCl buffer in the mixed solution D is 50 mM (mmol / L), the volume of the mixed solution D is 360 μL, and the pH of the Tris-HCl buffer is 6. The volumes of the 1-naphthyl sodium phosphate solution in the mixed solution C are 450 μL, the molar concentration of the 1-naphthyl sodium phosphate solution is 2.0 mM (mmol / L), and the volume of the solvent water is 810 μL.

[0043] (2) Mixed solution C was mixed with 180 μL of ALP solution (the ALP activity in the ALP solution was 0.9 U / mL, and the solvent of the ALP solution was water) and incubated in a constant temperature water bath at 37°C for 60 min to obtain mixed solution A.

[0044] (3) Mixed solution A was mixed with 200 μL of ethylenediamine solution (50% by volume, the solvent of the ethylenediamine solution was water) and placed at 37°C for 90 min to obtain mixed solution B. If the volume of mixed solution B was less than 2 mL, it was made up to 2 mL with deionized water.

[0045] (4) For each pH value, three samples were prepared in parallel and the fluorescence intensity at 479 nm in the fluorescence spectrum of mixed solution B obtained under the excitation of 355 nm light was measured.

[0046] Different from the above steps, the volume of ethylenediamine solution in step (3) is changed to 50 μL, 100 μL, 150 μL, 250 μL, and 300 μL, respectively, and the corresponding fluorescence intensity is detected. The volume of ethylenediamine solution in step (3) is 50 μL, and the volume of solvent water in step (1) is 960 μL. The volume of ethylenediamine solution in step (3) is 100 μL, and the volume of solvent water in step (1) is 910 μL. The volume of ethylenediamine solution in step (3) is 150 μL, and the volume of solvent water in step (1) is 860 μL. The volume of ethylenediamine solution in step (3) is 250 μL, and the volume of solvent water in step (1) is 760 μL. The volume of ethylenediamine solution in step (3) is 300 μL, and the volume of solvent water in step (1) is 710 μL.

[0047] Get as Figure 4 The results shown, Figure 4 In the above example, the volume of ethylenediamine solution is 50 μL, 100 μL, 150 μL, 200 μL, 250 μL, and 300 μL, and the corresponding volume fractions are 1.25%, 2.50%, 3.75%, 5.00%, 6.25%, and 7.50%, respectively. The volume fraction is the volume fraction of ethylenediamine relative to the mixed solution B. Figure 4 It can be seen that the fluorescence intensity gradually increases with the volume fraction of ethylenediamine in the mixed solution B, and the maximum fluorescence intensity is obtained at a volume fraction of 6.25%.

[0048] Example 4 (1) A mixed solution D of Tris-HCl buffer and MgCl2, a 1-naphthyl sodium phosphate solution (the solvent of the 1-naphthyl sodium phosphate solution is water) and solvent water are mixed to obtain a mixed solution C. The molar concentration of MgCl2 in the mixed solution D is 50 μM (μmol / L), the molar concentration of Tris-HCl buffer in the mixed solution D is 50 mM (mmol / L), the volume of the mixed solution D is 360 μL, and the pH of the Tris-HCl buffer is 6. The volumes of the 1-naphthyl sodium phosphate solution in the mixed solution C are 450 μL, the molar concentration of the 1-naphthyl sodium phosphate solution is 2.0 mM (mmol / L), and the volume of the solvent water is 810 μL.

[0049] (2) Mixed solution C was mixed with 180 μL of ALP solution (the ALP activity in the ALP solution was 0.9 U / mL, and the solvent of the ALP solution was water) and incubated in a constant temperature water bath at 37°C for 5 min to obtain mixed solution A.

[0050] (3) Mixed solution A was mixed with 200 μL of ethylenediamine solution (50% by volume, the solvent of the ethylenediamine solution was water) and placed at 37°C for 90 min to obtain mixed solution B. If the volume of mixed solution B was less than 2 mL, it was made up to 2 mL with deionized water.

[0051] (4) For each pH value, three samples were prepared in parallel and the fluorescence intensity at 479 nm in the fluorescence spectrum of mixed solution B obtained under the excitation of 355 nm light was measured.

[0052] Different from the above steps, the constant temperature water bath time in step (2) was gradually increased to 10 min, 15 min, 20 min, 25 min, 30 min, and 35 min, respectively, and the fluorescence intensity corresponding to each time point was detected to obtain the following: Figure 5 The results are shown. Figure 5 It can be seen that the corresponding maximum fluorescence intensity has been reached at 20 minutes and then no longer increases.

[0053] Example 5 (1) A mixed solution D of Tris-HCl buffer and MgCl2, a 1-naphthyl sodium phosphate solution (the solvent of the 1-naphthyl sodium phosphate solution is water) and solvent water are mixed to obtain a mixed solution C. The molar concentration of MgCl2 in the mixed solution D is 50 μM (μmol / L), the molar concentration of Tris-HCl buffer in the mixed solution D is 50 mM (mmol / L), the volume of the mixed solution D is 360 μL, and the pH of the Tris-HCl buffer is 6. The volumes of the 1-naphthyl sodium phosphate solution in the mixed solution C are 450 μL, the molar concentration of the 1-naphthyl sodium phosphate solution is 2.0 mM (mmol / L), and the volume of the solvent water is 810 μL.

[0054] (2) Mixed solution C was mixed with 180 μL of ALP solution (the ALP activity in the ALP solution was 0.9 U / mL, and the solvent of the ALP solution was water) and incubated in a constant temperature water bath at 37°C for 25 min to obtain mixed solution A.

[0055] (3) Mixed solution A with 200 μL of ethylenediamine solution (50% by volume, the solvent of ethylenediamine solution is water) and place at 37°C for 5 min to obtain mixed solution B. If the volume of mixed solution B is less than 2 mL, add deionized water to make up to 2 mL.

[0056] (4) For each pH value, three samples were prepared in parallel and the fluorescence intensity at 479 nm in the fluorescence spectrum of mixed solution B obtained under the excitation of 355 nm light was measured.

[0057] Different from the above steps, the constant temperature placement time in step (3) was gradually increased to 10 min and 60 min, respectively, and the fluorescence intensity corresponding to each time point was detected to obtain the following: Figure 6 The results are shown. Figure 6 It can be seen that the increase in reaction time after adding ethylenediamine has no significant effect on the fluorescence intensity.

[0058] Example 6 (1) A mixed solution D of Tris-HCl buffer and MgCl2, a 1-naphthyl sodium phosphate solution (the solvent of the 1-naphthyl sodium phosphate solution is water) and solvent water are mixed to obtain a mixed solution C. The molar concentration of MgCl2 in the mixed solution D is 50 μM (μmol / L), the molar concentration of Tris-HCl buffer in the mixed solution D is 50 mM (mmol / L), the volume of the mixed solution D is 360 μL, and the pH of the Tris-HCl buffer is 6. The volumes of the 1-naphthyl sodium phosphate solution in the mixed solution C are 450 μL, the molar concentration of the 1-naphthyl sodium phosphate solution is 2.0 mM (mmol / L), and the volume of the solvent water is 810 μL.

[0059] (2) Mixed solution C was mixed with 180 μL of ALP solution (the ALP activity in the ALP solution was different, and the solvent of the ALP solution was water) and kept in a constant temperature water bath at 37°C for 25 min to obtain mixed solution A.

[0060] (3) Mixed solution A with 200 μL of ethylenediamine solution (50% by volume, the solvent of ethylenediamine solution is water) and place at 37°C for 5 min to obtain mixed solution B. If the volume of mixed solution B is less than 2 mL, add deionized water to make up to 2 mL.

[0061] (4) For each pH value, three samples were prepared in parallel and the fluorescence intensity at 479 nm in the fluorescence spectrum of mixed solution B obtained under the excitation of 355 nm light was measured.

[0062] According to the above steps (1)-(4), ALP solutions with different ALP activities were tested. The ALP activities were 0, 1, 2, 3, 4, 5, 6, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 200, 300, 400, 600, 700, and 800 (in mU / mL respectively). Figure 7 , 8 , the results shown in 9, through Figure 7 , 8 9 can be obtained that when the ALP is less than 100mU / mL, the fluorescence intensity and the ALP activity are in a linear proportional relationship, and in the range of greater than 100 to 800mU / mL, a curvilinear change law is presented. Therefore, in the present application, the corresponding ALP activity can be obtained by detecting the fluorescence intensity.

[0063] Experimental Example 1 The cytotoxicity of 1-naphthyl sodium phosphate and ethylenediamine was tested using Hepg2 and LO2 cells. The 450 μM (μmol / L) 1-naphthyl sodium phosphate solution was diluted 100, 200, 300, 400, 500, and 1000 times, respectively, and then the 1-naphthyl sodium phosphate solution was mixed with Hepg2 and LO2 cells in the culture medium. Fig.10 , Fig.11 The results shown in the figure are as follows: the horizontal axis represents the dilution factor, and the vertical axis represents the cell survival rate. Fig.10 and Fig.11 It can be obtained that the cell survival rate is basically greater than 92%.

[0064] A 5% volume fraction ethylenediamine solution (solvent is water) was diluted 100, 200, 300, 400, 500, 1000 times, and then the ethylenediamine solution was mixed with Hepg2 and LO2 cells in the culture medium, and the cell survival rate was measured. Fig.12 , Fig.13 The results shown in the figure are as follows: the horizontal axis represents the dilution factor, and the vertical axis represents the cell survival rate. Fig.12 and Fig.13 The cell viability can be close to or greater than 90%.

[0065] Example 7 Take 1 million frozen Hpeg2 (human liver cancer cells), LO2 (human normal liver cells), 293T (human embryonic kidney cells), 4T1 (mouse breast cancer cells), RAW264.7 (mouse mononuclear macrophage leukemia cells), add 100 μL RIPA (lysis buffer) + 1 μL PMSF (Phenylmethylsulfonyl fluoride) and lyse on ice for 30 minutes, mix once every 5 minutes. Then centrifuge the lysed cells (4℃, 12000r, 10min). Add 360 μL Tris-HCl buffer (50 mM, pH=6) containing 50 μM MgCl2, 450 μL sodium 1-naphthylphosphate (2.0 mM), 890 μL deionized water and 100 μL lysate of different cells, and keep them in a constant temperature water bath at 37℃ for 25 minutes. Then, 200 μL of ethylenediamine (50% by volume) was added to the mixed solution and kept in a water bath at 37°C for 10 min. Three samples were paralleled in each group and the fluorescence intensity was measured under 355 nm excitation. Fig.14 The fluorescence results shown are Fig.14 It can be obtained that the fluorescence intensity corresponding to Hpeg2 is about 700 (au), the fluorescence intensity corresponding to LO2 is about 550 (au), the fluorescence intensity corresponding to 293T is about 230 (au), the fluorescence intensity corresponding to 4T1 is about 180 (au), and the fluorescence intensity corresponding to RAW264.7 is about 180 (au). Through the linear proportional relationship between ALP activity and fluorescence intensity, it is obtained as follows Fig.15 The ALP activity results shown are that the ALP activities corresponding to Hpeg2, LO2, 293T, 4T1, and RAW264.7 are approximately 23, 17.5, 5, 2.5, and 2.5 mU / mL, respectively.

[0066] Example 8 360 μL of Tris-HCl buffer (50 mM, pH=6) containing 50 μM MgCl2, 450 μL of sodium 1-naphthylphosphate (2.0 mM), 200 μL of serum diluted 100 times and 0 / 20 / 60 / 100 μL ALP were added respectively, and the total amount of solution was 2 mL with deionized water, and the mixture was kept in a constant temperature water bath at 37°C for 25 min. Then 200 μL of ethylenediamine (50% by volume) was added to the mixed solution, and the mixture was kept in a constant temperature water bath at 37°C for 10 min. Three samples were paralleled in each group, and the fluorescence intensity was measured under 355 nm excitation. The results are shown in Table 1 and Fig.16 Results shown.

[0067] Table 1 Detection results and standard deviations of different ALP activities Through Table 1 and Fig.16 It can be obtained that the standard deviation between the ALP activity detected in the present application and the actual ALP activity is less than 21%.

[0068] Example 9 The heart, liver, spleen, lung and kidney of tumor mice and normal mice were weighed separately and placed in containers and ground into powder. 1 mL RIPA + 10 μL PMSF were added and mixed evenly. The mixed liquid was centrifuged (4°C, 4000r, 4min) and the supernatant was taken.

[0069] 360 μL of Tris-HCl buffer (50 mM, pH=6) containing 50 μM MgCl2, 450 μL of sodium 1-naphthylphosphate (2.0 mM), 50 / 100 / 150 μL of mouse organ supernatant, respectively, and deionized water was added to make the total solution 2 mL, and the mixture was kept in a constant temperature water bath at 37°C for 25 min. Then 200 μL of ethylenediamine (50% by volume) was added to the mixed solution, and the mixture was kept in a constant temperature water bath at 37°C for 10 min. Three samples were paralleled in each group, and the fluorescence intensity was measured under 355 nm excitation.

[0070] The fluorescence intensity of each organ of the tumor mouse is as follows Fig.17 As shown, Fig.17 and Fig.18 In the figure, Liver means liver, Spleen means spleen, Kidney means kidney, Lung means lung, and Heart means heart. The ALP activities of various organs of tumor mice are shown in Figure 2. Fig.18 As shown. Fig.17 and Fig.18 It can be obtained that the fluorescence detection method of the present application can obtain the ALP activity of various organs of tumor mice.

[0071] The fluorescence intensity of each organ of a normal mouse is as follows: Fig.19 As shown, the ALP activities of various organs of tumor mice are as follows Fig. 20 As shown, Fig.19 and Fig. 20 In Chinese, Liver means liver, Spleen means spleen, Kidney means kidney, Lung means lung, and Heart means heart. Fig.19 and Fig. 20 It can be obtained that the fluorescence detection method of the present application can obtain the ALP activity of various organs of normal mice.

[0072] pass Fig.17 , Fig.18 , Fig.19 and Fig. 20 It can be found that among various organs of normal mice and tumor mice, the ALP activity in the liver is the highest and the ALP activity in the heart is the lowest.

[0073] In addition, although exemplary embodiments have been described herein, the scope includes any and all embodiments based on the present application with equivalent elements, modifications, omissions, combinations (e.g., various embodiments intersecting schemes), adaptations or changes. The elements in the claims are to be interpreted broadly based on the language adopted in the claims, and are not limited to the examples described in this specification or during the practice of this application, and the examples are to be interpreted as non-exclusive. Therefore, this specification and examples are intended to be considered as examples only, and the true scope and spirit are indicated by the following claims and the full scope of their equivalents.

[0074] The above description is intended to be illustrative rather than restrictive. For example, the above examples (or one or more schemes thereof) may be used in combination with each other. For example, a person of ordinary skill in the art may use other embodiments when reading the above description. In addition, in the above-mentioned specific embodiments, various features may be grouped together to simplify the present application. This should not be interpreted as an intention that a feature of an application that does not require protection is necessary for any claim. On the contrary, the subject matter of the present application may be less than all the features of an embodiment of a particular application. Thus, the following claims are incorporated herein in the specific embodiments as examples or embodiments, wherein each claim is independently a separate embodiment, and it is considered that these embodiments may be combined with each other in various combinations or arrangements. The scope of the present invention should be determined with reference to the appended claims and the full scope of equivalent forms granted by these claims.

[0075] The above embodiments are only exemplary embodiments of the present application and are not intended to limit the present invention. The protection scope of the present invention is defined by the claims. Those skilled in the art may make various modifications or equivalent substitutions to the present invention within the essence and protection scope of the present application, and such modifications or equivalent substitutions shall also be deemed to fall within the protection scope of the present invention.

Claims

1. A fluorescence detection method for alkaline phosphatase activity, It is characterized in that The fluorescence detection method comprises: mixing a substrate with a test liquid, wherein the substrate comprises sodium 1-naphthylphosphate, reacting to generate naphthol, and obtaining a mixed solution A; mixing the mixed solution A with ethylenediamine, and obtaining a mixed solution B after reaction; and using a fluorescence spectrometer to perform fluorescence detection on the fluorescence generated by the mixed solution B under the excitation of a light wavelength of 355 nm, and obtaining the concentration of alkaline phosphatase in the test liquid.

2. The fluorescence detection method according to claim 1, It is characterized in that The method comprises: performing fluorescence detection on the fluorescence generated by the mixed solution B under the excitation of the light wavelength of 355nm by using a fluorescence spectrometer to obtain the activity of the alkaline phosphatase to be tested, comprising: performing fluorescence detection on the fluorescence generated by the mixed solution B under the excitation of the light wavelength of 355nm by using a fluorescence spectrometer to obtain a fluorescence spectrum; obtaining the fluorescence intensity at 479nm based on the fluorescence spectrum; and obtaining the activity of the alkaline phosphatase based on the linear relationship between the fluorescence intensity at 479nm and the activity of the alkaline phosphatase.

3. The fluorescence detection method according to claim 1, It is characterized in that The substrate comprises a 1-naphthyl sodium phosphate solution, wherein the concentration of the 1-naphthyl sodium phosphate in the 1-naphthyl sodium phosphate solution is 200-600 μmol / L; and the volume ratio of the 1-naphthyl sodium phosphate solution to the liquid to be tested is 1-4:

1.

4. The fluorescence detection method according to claim 1, It is characterized in that The mixed solution A and the ethylenediamine solution are mixed and reacted, wherein the volume ratio of the mixed solution A to the ethylenediamine solution is 5-40:1; the volume fraction of the ethylenediamine solution is 40-60%; and the volume fraction of the ethylenediamine in the mixed solution B is 1-15%.

5. The fluorescence detection method according to claim 1, It is characterized in that The reaction time of mixing 1-naphthyl sodium phosphate with the test solution is 5-80 minutes; the reaction time of mixing the mixed solution A with ethylenediamine is 5-100 minutes.

6. The fluorescence detection method according to claim 1, It is characterized in that The concentration range of alkaline phosphatase in the test solution is 0-800 mU / mL.

7. The fluorescence detection method according to claim 1, It is characterized in that The substrate also includes a mixed solution D, which includes MgCl 2 and Tris-HCl buffer.

8. The fluorescence detection method according to claim 1, It is characterized in that The temperature for the mixed reaction of the substrate and the test solution is 30-40°C; the temperature for the mixed reaction of the mixed solution A and ethylenediamine is 30-40°C.

9. Use of the fluorescence detection method according to any one of claims 1 to 8 in detecting alkaline phosphatase activity in cells, serum and / or organs.

10. The use according to claim 9, It is characterized in that The cells include tumor cells and / or normal cells.